In a news release, GSU said MK-4482/EIDD-2801, or Molnupiravir, has appeared to suppress the transmission of the coronavirus within just 24 hours.
“This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission,” said Dr. Richard Plemper, the professor at Georgia State who led the group. "MK-4482/EIDD-2801 could be game-changing.”
Researchers said that since this is an oral drug, treatment can be started early for a potentially three-fold benefit:
https://www.thehansindia.com/telang...2-deaths-in-telangana-660034?infinitescroll=1
https://www.nature.com/articles/s41564-020-00835-2
“This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission,” said Dr. Richard Plemper, the professor at Georgia State who led the group. "MK-4482/EIDD-2801 could be game-changing.”
Researchers said that since this is an oral drug, treatment can be started early for a potentially three-fold benefit:
- inhibiting patients’ progress to severe disease
- shortening the infectious phase
- rapidly silence local outbreaks
https://www.thehansindia.com/telang...2-deaths-in-telangana-660034?infinitescroll=1
https://www.nature.com/articles/s41564-020-00835-2
